相关实验视频
Updated: Jan 23, 2026

06:40
Seven Steps to Stellate Cells
Published on: May 10, 2011
34.7K
肝纤维化中的肝细胞-肝星细胞相互作用:机制和治疗含义
Zihan Wang1,2, Zixuan Cao2, Yunsheng Dong2,3
1Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Hepatology communications
|January 21, 2026
概括
肝纤维化涉及肝细胞和肝星细胞 (HSC) 之间的复杂交叉. 了解这些相互作用是开发肝纤维化新疗法的关键.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 细胞生物学 细胞生物学
- 分子机制的分子机制
背景情况:
- 肝纤维化是一种由慢性肝损伤驱动的病理过程.
- 它涉及到肝星细胞 (HSC) 和细胞外基质 (ECM) 积累的激活.
- 肝细胞和HSC之间的复杂通信是纤维化进展的核心.
研究的目的:
- 在肝纤维化中审查肝细胞和肝细胞细胞之间的双向交叉.
- 阐明控制这些细胞与细胞相互作用的分子机制.
- 讨论针对肝纤维化的当前挑战和未来方向.
主要方法:
- 文献综述侧重于肝细胞-HSC相互作用的分子机制.
- 对肝纤维化中关键信号通路的分析.
- 讨论治疗策略和未来的研究途径.
主要成果:
- 肝细胞损伤会触发释放媒介体,这些媒介体会激活肝细胞细胞,从而促进纤维化.
- 激活的HSCs通过细胞因子,ECM重塑和机械压力促进肝细胞功能障碍.
- 转化生长因子-β (TGF-β),血小板衍生生长因子 (PDGF) 和氧化应激是关键途径.
结论:
- 肝细胞和肝细胞细胞之间的双向交叉是肝纤维化至关重要的复杂调节网络.
- 针对这种复杂的网络提出了挑战,但为新的治疗策略提供了潜力.
- 建议在未来的研究中使用多omics技术来解开动态的时空相互作用.
更多相关视频
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
188
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
188
Cystic Fibrosis: Pathogenesis
740
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
740
Cell Specific Gene Expression
16.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.3K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K

